These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3304169)

  • 1. [Effects of recombinant human interferon-alpha A/D on the growth of experimental tumors in mice].
    Ootsu K; Kozai Y; Houkan T; Gotoh K; Matsutani E
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2502-8. PubMed ID: 3304169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.
    Iigo M; Sakurai M; Tamura T; Saijo N; Hoshi A
    Cancer Res; 1988 Jan; 48(2):260-4. PubMed ID: 2446744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of recombinant human interferon alpha A/D on Meth-A sarcoma in mice.
    Yoshie O; Aso H; Nanjo M; Tamura K; Ebina T; Ishida N
    Jpn J Cancer Res; 1986 Apr; 77(4):413-8. PubMed ID: 3084432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice].
    Hashizume S
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):284-8. PubMed ID: 3970552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
    Nakamura S; Nakata K; Kashimoto S; Yoshida H; Yamada M
    Jpn J Cancer Res; 1986 Aug; 77(8):767-73. PubMed ID: 3093425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor effect of human recombinant interferon-alpha A/D in mice(I): Comparison between systemic and lesional treatment of meth-A sarcoma in BALB/c mice].
    Nanjo M; Yoshie O; Aso H; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):505-9. PubMed ID: 4004283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin-2 and interferon-beta treatment on lymphocytes in various tumor-bearing mice.
    Iigo M; Nishikata K; Nakajima Y; Moriyama M
    J Biol Regul Homeost Agents; 1989; 3(3):108-11. PubMed ID: 2516403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.
    Cameron RB; McIntosh JK; Rosenberg SA
    Cancer Res; 1988 Oct; 48(20):5810-7. PubMed ID: 3262413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
    Kondo H; Tanaka N; Naomoto Y; Orita K
    Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity elicited by recombinant interferons alpha and gamma when administered in combination to tumor-bearing mice.
    Truitt GA; Bontempo JM; Stern LL; Sulich V; Bellantoni D; Trown PW; Brunda MJ
    Biotechnol Ther; 1989-1990; 1(1):1-16. PubMed ID: 2562640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.
    Kataoka T; Matsuura N; Oh-hashi F; Suhara Y
    Cancer Res; 1985 Aug; 45(8):3548-53. PubMed ID: 2410097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant interleukin-1 alpha, recombinant interleukin-2, recombinant interferon-beta, and recombinant tumor necrosis factor on subcutaneously implanted adenocarcinoma 755 and Lewis lung carcinoma.
    Iigo M; Nishikata K; Hoshi A
    J Biol Response Mod; 1990 Aug; 9(4):426-30. PubMed ID: 2395006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines.
    Fidler IJ; Heicappell R; Saiki I; Grutter MG; Horisberger MA; Nuesch J
    Cancer Res; 1987 Apr; 47(8):2020-7. PubMed ID: 3828990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor effect of interferons].
    Ebina T; Saito M
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):24-35. PubMed ID: 6421241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human interferon-alpha A/D on in vivo murine tumor cell growth.
    Uno K; Shimizu S; Inaba K; Kitaura M; Nakahira K; Kato T; Yamaguchi Y; Muramatsu S
    Cancer Res; 1988 May; 48(9):2366-71. PubMed ID: 3356004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of human recombinant interferon-gamma alone and in combination with adriamycin on a human colon cancer cell line (RPMI 4788) in vitro and in nude mice.
    Kondo H; Tanaka N; Orita K
    Jpn J Cancer Res; 1987 Dec; 78(12):1400-8. PubMed ID: 3123441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contribution of antiproliferative and host immunity-associated activity of mouse interferon in murine tumor therapy.
    Kataoka T; Oh-hashi F; Sakurai Y; Usuki K; Ida N
    Cancer Res; 1984 Dec; 44(12 Pt 1):5661-5. PubMed ID: 6498826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.